Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Cormier

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogensOlivier Cussenot, Abdel Rhamene Azzouzi, Nathalie Nicolaiew, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2021
Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney SamplesElise Marechal, Adrien Jaugey, Georges Tarris, et al.
European Urology Oncology|February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 StudyDavid Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
BJU International|June 19, 2012
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification toolFrançois Audenet, Pierre Colin, David R Yates, et al.
European Urology|June 14, 2011
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Evanguelos Xylinas, et al.
World Journal of Urology|December 12, 2012
The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Tarek P Ghoneim, et al.
European Urology|June 30, 2021
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
The New England Journal of Medicine|June 5, 2018
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaArnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
Annals of Surgical Oncology|October 31, 2013
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French studyGéraldine Pignot, Laurent Salomon, Yann Neuzillet, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogensOlivier Cussenot, Abdel Rhamene Azzouzi, Nathalie Nicolaiew, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2021
Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney SamplesElise Marechal, Adrien Jaugey, Georges Tarris, et al.
European Urology Oncology|February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 StudyDavid Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
BJU International|June 19, 2012
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification toolFrançois Audenet, Pierre Colin, David R Yates, et al.
European Urology|June 14, 2011
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Evanguelos Xylinas, et al.
World Journal of Urology|December 12, 2012
The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Tarek P Ghoneim, et al.
European Urology|June 30, 2021
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
The New England Journal of Medicine|June 5, 2018
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaArnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
Annals of Surgical Oncology|October 31, 2013
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French studyGéraldine Pignot, Laurent Salomon, Yann Neuzillet, et al.
Pageof 9